(19)
(11) EP 4 798 609 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883314.7

(22) Date of filing: 24.10.2024
(51) International Patent Classification (IPC): 
C07K 14/005(2006.01)
A61P 31/14(2006.01)
A61K 39/215(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/005; A61P 31/14; C12N 2770/20034; C12N 2770/20022; A61K 39/12; A61K 2039/55555; A61K 2039/575; A61K 2039/54; A61K 2039/545; A61K 2039/57; A61K 2039/555
(86) International application number:
PCT/US2024/052777
(87) International publication number:
WO 2025/090742 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 26.10.2023 US 202363593422 P

(71) Applicant: Duke University
Durham, NC 27705 (US)

(72) Inventors:
  • SAUNDERS, Kevin
    Durham, North Carolina 27705 (US)
  • HAYNES, Barton F.
    Durham, North Carolina 27705 (US)
  • YU, Jae-Sung
    Durham, North Carolina 27705 (US)
  • LEE, Esther
    Durham, North Carolina 27705 (US)

(74) Representative: Barker Brettell LLP 
100 Hagley Road Edgbaston
Birmingham, West Midlands B16 8QQ
Birmingham, West Midlands B16 8QQ (GB)

   


(54) CORONAVIRUS RECEPTOR BINDING DOMAIN (RBD) NANOPARTICLE VACCINES